Pulmonology Clinical Studies

Asthma Attacks and Vitamin D Deficiency – Phase II

Vitamin D to Prevent Severe Asthma Exacerbations (Vit-D-Kids Asthma)

Asthma Registry

Asthma Treatment with Steroids: The SIENA Study – Phase III

Steroids in Eosinophil-Negative Asthma (SIENA)

Biomarkers of Lung Disease

Biomarkers of Lung Disease in Bronchoalveolar Lavage Fluid

Cough Study for Males with Neuromuscular Disease – Pilot

Cough Peak Flow And Airway Clearance in Pediatric Patients with Neuromuscular Disease

Cow’s Milk Allergy Treatment with Viaskin Milk Patch – Phase I/II

Trial to Study the Efficacy and Safety of Viaskin Milk for Treating IgE-Mediated Cow’s Milk Allergy in Children

CF Patient Registry

Participation in the Cystic Fibrosis Patient Registry

Cystic Fibrosis, Aspergillosis & the Effect of Vitamin D

Open-label Vitamin D Trial for Patients with Cystic Fibrosis and Allergic Bronchopulmonary Aspergillosis

Cystic Fibrosis & the Effects of Inhaled Bicarbonate

Effects of Inhaled Bicarbonate on Airway pH in Cystic Fibrosis

Genetic Modifiers of Cystic Fibrosis

Immunological Factors of Lung Functions

Mechanisms of Immune Tolerance and Inflammation in Allergic Bronchopulmonary Aspergillosis (ABPA) in Patients with Cystic Fibrosis

Peanut Allergy Treatment Using Viaskin® Patch – Phase III

Trial to Assess Peanut Epicutaneous Immunotherapy Efficacy and Safety (PEPITES) with Viaskin Peanut in Peanut-Allergic Children

Peanut Allergy Treatment with AR101 Oral Immunotherapy – Phase III

Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitation in Children and Adults (PALISADE)

Severe Asthma Investigation

Severe Asthma Research Program: Inflammation, Myofibroblasts and Loss of Elastic Recoil in Severe Asthma

Sleep Disorders Registry

The EPIC Observational Study

The EPIC Observational Study: Long-Term Study of Risk Factors and Impact of Pseudomonas aeruginosa and Early Anti-Pseudomonal Treatment in Children with Cystic Fibrosis